Zacks Investment Research on MSN
Merck & Co., Inc. (MRK) is attracting investor attention: Here is what you should know
Merck (MRK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...
Zacks Investment Research on MSN
Merck (MRK) stock sinks as market gains: Here's why
Merck (MRK) closed at $123.54 in the latest trading session, marking a -1.22% move from the prior day. This change lagged the S&P 500's 0.42% gain on the day. Meanwhile, the Dow gained 0.29%, and the ...
Shares of Merck & Co. Inc. MRK rallied 1.64% to $128.86 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.45% to 7,503.85 and ...
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its first-quarter 2025 sales and earnings conference call with institutional investors ...
Merck, a leading science and technology company, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to enpatoran for the treatment of lupus ...
AstraZeneca is paying Sino Biopharmaceutical $200 million upfront for ex-China rights to a late-phase challenger to Merck & ...
Newsable Asianet News on MSN
MRK, NEUP Stocks Drop As Merck Scraps Another Alzheimer’s Drug Trial Under Neuphoria Partnership
Merck cited business reasons for the discontinuation of the investigational drug.
Merck & Co., Inc. (MRK), headquartered in Rahway, New Jersey, is a major player in healthcare. Specializing in pharmaceuticals, vaccines, and animal health, Merck is committed to delivering innovative ...
Merck & Co., Inc. (NYSE: MRK) has had a fantastic six months, seeing its share price go up nearly 50%. The company has a valuable portfolio of assets that will enable strong shareholder returns, ...
Germany’s Merck KGaA will buy Bio-Techne Corp. in a deal worth $11.3 billion, one of the largest acquisitions in Minnesota history. The sale follows investor pressure on Minneapolis-based Bio-Techne, ...
Merck (MRK) closed the most recent trading day at $128.66, moving +2.56% from the previous trading session. The stock's ...
RAHWAY, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Orna Therapeutics, a biotechnology company pioneering a new investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results